Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.93 0.04(4.12%) Jul 30, 3:59PM EDT
|Pre-Market : NaN
Prev Close:0.97
Open:0.97
Bid:N/A
Ask:N/A
1y Target Est:4.00
Beta:1.13
Next Earnings Date:N/A
Day's Range:0.88 - 0.97
52wk Range:0.88 - 4.79
Volume:288,112
Avg Vol (3m):311,402
Market Cap:86.51M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVIV

Comparison

Symbol% ChgMkt Cap
NVIVDown 4.12%86.51M
ACOR1.22B
ALSE1.00M
STEM95.48M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Jun-14) :-0.06
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biomaterial technologies for the treatment of spinal cord injuries and hydrogels for therapeutics delivery. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback